30+ Experts Question Validity of Serotonin/Depression Study at AshTip Solution.

BORDEAUX, France — Could AEF0117, a drug that has a novel mechanism of action in the brain, be the drug to fight cannabis addiction? Results from a phase 2a clinical trial that examined the efficacy of AEF0117 in patients with cannabis use disorder have created quite a stir. The study was published in Nature Medicine. Not only did AEF0117 weaken the effects of cannabis, but it also decreased a person's desire to use it, all without causing withdrawal symptoms. These findings have generated a significant buzz in the scientific and medical community. 2023-06-23

Cognitive-behavioral therapy (CBT) may deserve a place alongside ablation and rhythm- and rate-control drugs as a management option for some people with paroxysmal atrial fibrillation (AF), a new study suggests. 2023-06-30

A catch-up screening test for human papillomavirus (HPV) may improve cancer prevention and detection in women older than 65 years, according to a new study. 2023-07-07

Opioid-related deaths are increasing among youths aged 15 to 24 years in the province of Ontario, Canada, while the use of opioid agonist treatment (OAT) is declining, according to new research. 2023-07-14

Initiating oxycodone instead of codeine for postpartum analgesia was associated with an increased risk of persistent opioid use after vaginal, but not cesarean, delivery, new research suggests. 2023-08-01